z-logo
open-access-imgOpen Access
Lead Stores in Patients with Renal Insufficiency
Author(s) -
B. T. Emmerson
Publication year - 1991
Publication title -
˜the œnephron journals/nephron journals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.951
H-Index - 72
eISSN - 2235-3186
pISSN - 1660-8151
DOI - 10.1159/000186421
Subject(s) - medicine , intensive care medicine , nephrology , kidney disease , endocrinology
Prof.B.T. Emmerson, University of Queensland Department of Medicine, Princess Alexandra Hospital, Brisbane, Qld 4102 (Australia) Dear Sir, A recent paper by Winterberg et al. [1] entitled ‘Lead Overload in Patients with Renal Insufficiency’ has considered the question of whether lead overload develops in haemodialysis patients and concluded that the answer is clearly in the affirmative. They presented the bone lead concentrations of control subjects, of patients with chronic renal failure, of haemodialysis patients and of patients after renal transplantation, none of whom were known to have had lead exposure, and concluded that the lead body burden depended on renal function. Our extensive experience in Queensland, Australia, with chronic lead nephropathy following childhood lead poisoning, provides contrary data which we believe is relevant to the current consideration of this question. Childhood lead poisoning became common in Queensland after 1890 and was followed some years later by the development of chronic renal failure. This varied in severity so that the most severely affected died in their teens and the less severely affected cohorts lived for 40 or 50 years. This childhood lead poisoning resulted in a great increase in the incidence of granular contracted kidneys in Queensland in the first half of this century. After lead paint was outlawed by legislation in the 1920s, this increased incidence of granular contracted kidneys steadily subsided until it was similar to that in the rest of Australia some 30 or 40 years later. The epidemiological follow-up of subjects with childhood lead poisoning was undertaken by Henderson [2] who also studied the lead content ofbone in patients with granular contracted kidneys in Queensland [3]. These studies showed that the bone lead content of persons with chronic renal disease of known aetiology (not due to lead) is the same as for persons who died without chronic renal failure, whereas much higher values were found in those persons with granular contracted kidneys following childhood lead poisoning (chronic lead nephropathy). Later studies of the lead content ofbone in subjects without recognized past lead exposure in Queensland and in patients with chronic renal disease showed that the lead content of bone in patients with renal disease not due to lead was within the range of normal subjects, whereas the values of lead in bone for subjects with chronic lead nephropathy were elevated [4]. Additional information was provided by the amount of lead excreted in the urine after a standardized infusion of calcium EDTA. This was measured in normal subjects, in subjects with chronic lead nephropathy and in patients with chronic renal insufficiency attributable to causes other than childhood lead poisoning [5, 6]. This showed that, except possibly in patients with polycystic kidney disease, the lead excreted after EDTA in subjects with chronic renal disease due to causes other than childhood lead poisoning was in the normal range for that population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom